Skip to Main Navigation

Bhutan: COVID-19 Emergency Response and Health Systems Preparedness Project

Abstract*

The project development objective is to prevent, detect and respond to the threat posed by COVID-19 and to strengthen national systems for public health preparedness in Bhutan. It will achieve this objective by supporting Bhutan, and specifically the Ministry of Health, to (i) provide emergency COVID-19 response, including case detection, confirmation, contact tracing, recording, reporting and health system strengthening ; (ii) enhance community engagement...

* The project abstract is drawn from the PAD, SAR or PGD and may not accurately reflect the project's current nature

Show More

Development Objective

To prevent, detect and respond to the threat posed by COVID-19 and to strengthen national systems for public health preparedness in Bhutan

Key Details

Project Details

  • P173787

  • Closed

  • Phoebe Folger

  • Kingdom of Bhutan

  • Bhutan

  • April 11, 2020

  • (as of board presentation)

    April 17, 2020

  • April 27, 2020

  • US$ 5.00 million

  • Ministry of Health, Royal Government of Bhutan

  • South Asia

  • 2020

  • US$ 5.00 million

  • N/A

  • March 5, 2024

  • June 30, 2024

  • No

  • BANK APPROVED

  • Notes

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
IDA Credit 5.00

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment N/A
IDA Commitment 5.00
IBRD + IDA Commitment 5.00
Lending Instrument
Grant Amount N/A
Total Project Cost** 5.00

Summary Status of World Bank Financing (US$ Millions) as of February 28, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of February 28, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)
May 5, 2021 IDA-66270 Loan Disb 29,358.12
Mar 15, 2021 IDA-66270 Int Charges 69.82
Mar 15, 2021 IDA-66270 Int Charges 69.82
Mar 15, 2021 IDA-66270 Int Charges 10,400.98
Mar 15, 2021 IDA-66270 Int Charges 10,400.98
Nov 23, 2020 IDA-66270 Loan Disb 459,684.00
Oct 27, 2020 IDA-66270 Loan Disb 743,715.56
Sep 15, 2020 IDA-66270 Int Charges 3,666.43
Sep 15, 2020 IDA-66270 Int Charges 3,666.43
May 29, 2020 IDA-66270 Loan Disb 993,904.06
Jun 24, 2020 IDA-66270 Loan Disb 850,268.80
Mar 21, 2022 IDA-66270 Loan Disb 23,694.24
Sep 15, 2021 IDA-66270 Int Charges 87.39
Sep 15, 2021 IDA-66270 Int Charges 87.39
Sep 15, 2021 IDA-66270 Int Charges 11,668.02
Sep 15, 2021 IDA-66270 Int Charges 11,668.02
Aug 26, 2021 IDA-66270 Loan Disb 45,377.28
Sep 15, 2022 IDA-70980 Int Charges 8,347.72
Sep 15, 2022 IDA-70980 Int Charges 8,347.72
Sep 1, 2022 IDA-70980 Loan Disb 20,637.46
Mar 10, 2022 IDA-66270 Loan Disb 2,000,000.00
Aug 23, 2022 IDA-70980 Loan Disb 522,698.00
Jun 27, 2022 IDA-70980 Loan Disb 440,000.00
Jun 21, 2022 IDA-70980 Loan Disb 4,458,728.00
Mar 15, 2022 IDA-66270 Int Charges 28.76
Mar 15, 2022 IDA-66270 Int Charges 28.76
Mar 15, 2022 IDA-66270 Int Charges 11,783.95
Mar 15, 2022 IDA-66270 Int Charges 11,783.95
Mar 15, 2023 IDA-70980 Int Charges 156.69
Mar 15, 2023 IDA-70980 Int Charges 156.69
Mar 15, 2023 IDA-66270 Int Charges 199.69
Mar 15, 2023 IDA-66270 Int Charges 199.69
Mar 15, 2023 IDA-66270 Int Charges 18,262.86
Mar 15, 2023 IDA-66270 Int Charges 18,262.86
Mar 15, 2023 IDA-70980 Int Charges 20,652.76
Mar 15, 2023 IDA-70980 Int Charges 20,652.76
Sep 15, 2023 IDA-66270 Int Charges 238.12
Sep 15, 2023 IDA-66270 Int Charges 238.12
Sep 15, 2023 IDA-66270 Int Charges 18,050.78
Sep 15, 2023 IDA-66270 Int Charges 18,050.78
Jan 25, 2023 IDA-70980 Loan Disb 926,726.80
Apr 28, 2023 IDA-70980 Loan Disb 23,686.39
Sep 15, 2022 IDA-66270 Int Charges 33.05
Sep 15, 2022 IDA-66270 Int Charges 33.05
Sep 15, 2022 IDA-66270 Int Charges 17,922.88
Sep 15, 2022 IDA-66270 Int Charges 17,922.88
Jul 3, 2024 IDA-70980 Loan Disb 53.87
Sep 15, 2023 IDA-70980 Int Charges 680.68
Sep 15, 2023 IDA-70980 Int Charges 680.68
Sep 15, 2023 IDA-70980 Int Charges 23,657.65
Sep 15, 2023 IDA-70980 Int Charges 23,657.65
Apr 18, 2022 IDA-70980 Loan Commitment 10,000,000.00
Apr 17, 2020 IDA-66270 Loan Commitment 5,000,000.00
May 9, 2024 IDA-70980 Loan Cancel 3,032,550.00
Jul 3, 2024 IDA-70980 Loan Disb 40,718.36
Mar 15, 2024 IDA-70980 Int Charges 660.55
Mar 15, 2024 IDA-70980 Int Charges 660.55
Mar 15, 2024 IDA-70980 Int Charges 23,249.15
Mar 15, 2024 IDA-70980 Int Charges 23,249.15
Mar 15, 2024 IDA-66270 Int Charges 496.35
Mar 15, 2024 IDA-66270 Int Charges 496.35
Mar 15, 2024 IDA-66270 Int Charges 17,971.18
Mar 15, 2024 IDA-66270 Int Charges 17,971.18

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name Review Date
Progress towards achievement of PDO Satisfactory 2025-03-17
Financial Management Satisfactory 2025-03-17
Procurement Moderately Satisfactory 2025-03-17
Project Management Satisfactory 2025-03-17
Monitoring and Evaluation Satisfactory 2025-03-17
Overall Implementation Progress (IP) Satisfactory 2025-03-17

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATORBASELINECURRENTTARGET
  • Bhutan has activated its public health Emergency Operations Centre or a coordination mechanism for COVID-19ValueNoYesYes
    DateJanuary 10, 2020June 1, 2023December 31, 2023
    Comment
  • Percentage of suspected cases of COVID-19 cases reported and investigated based on national guidelinesValue0.00100.0090.00
    DateJanuary 10, 2020June 1, 2023December 31, 2023
    Comment
  • Number of acute healthcare facilities with isolation capacityValue1.004.003.00
    DateJanuary 10, 2020June 1, 2023December 31, 2023
    Comment
  • Country adopted personal and community non-pharmaceutical interventionsValueNoYesYes
    DateJanuary 10, 2020June 1, 2023December 31, 2023
    Comment
  • Percentage of population vaccinated, which is included in the priority population targets defined in national plan [by gender]Value0.008.305.60
    DateSeptember 29, 2021June 1, 2023December 31, 2023
    Comment
  • Percentage of males vaccinatedValue0.0048.6050.00
    DateDecember 15, 2021June 1, 2023December 31, 2023
    Comment
  • Percentage of females vaccinatedValue0.0051.4050.00
    DateDecember 15, 2021June 1, 2023December 31, 2023
    Comment
  • Percentage of population boosted with a single vaccine dose, in line with WHO/SAGE guidanceValue0.0045.8028.00
    DateMay 1, 2022June 1, 2023December 31, 2023
    Comment
  • Percentage of males boosted with a single vaccine dose, in line with WHO/SAGE guidanceValue0.0050.5050.00
    DateMay 1, 2022June 1, 2023December 31, 2023
    Comment
  • Percentage of females boosted with a single vaccine dose, in line with WHO/SAGE guidanceValue0.0049.5050.00
    DateMay 1, 2022June 1, 2023December 31, 2023
    Comment

INTERMEDIATE RESULTS INDICATORS

INDICATORBASELINECURRENTTARGET
  • Number of health staff trained in infection prevention and control per MoH protocolsValue0.00353.00100.00
    DateJanuary 10, 2020June 1, 2023December 31, 2023
    Comment
  • Bhutan has contextualized its risk communication and community engagement strategiesValueNoYesYes
    DateJanuary 10, 2020June 1, 2023December 31, 2023
    Comment
  • M&E system established to monitor COVID-19 preparedness and response planValueNoYesYes
    DateJanuary 10, 2020June 1, 2023December 31, 2023
    Comment
  • Percentage of specimens submitted for SARS-COV2 laboratory testing and confirmed within WHO stipulated standard timeValue0.00100.0095.00
    DateJanuary 10, 2020June 1, 2023December 31, 2023
    Comment
  • Percentage of received grievances that are addressed (within specified time/protocol)Value0.00100.0080.00
    DateJanuary 10, 2020June 1, 2023December 31, 2023
    Comment
  • Joint supervision and monitoring visits conductedValue0.005.006.00
    DateJanuary 10, 2020June 30, 2023December 31, 2023
    Comment
  • Number of acute healthcare facilities with triage capacityValue1.004.0010.00
    DateJanuary 10, 2020June 1, 2023December 31, 2023
    Comment
  • A National Vaccination and Deployment Plan (NVDP) with input from relevant bodies (NITAG, DRA, National Immunization Program, National Regulatory Authority, AEFI committee), in line with WHO guidanceValueNoYesYes
    DateDecember 31, 2020June 1, 2023December 31, 2023
    Comment
  • Potential numbers of target populations estimated who will be prioritized for access to vaccines stratified by target group and geographic locationValueNoYesYes
    DateDecember 31, 2020June 1, 2023December 31, 2023
    Comment
  • Guidelines, documented procedures and tools for planning and conducting vaccine pharmacovigilance activities establishedValueNoYesYes
    DateDecember 31, 2020June 1, 2023December 31, 2023
    Comment